Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 493

The DOI matches its Crossref record; 187 of the 187 references it cites were found in a registry or an index.

Epidemiology, Pathophysiology and Contemporary Management of Cardiogenic Shock – A Position Statement from the Heart Failure Association of the European Society of Cardiology

Open access
Chioncel, Ovidiu, Parissis, John, Mebazaa, Alexandre, Thiele, Holger, Desch, Steffen, Bauersachs, Johann, Harjola, Veli-Pekka, Antohi, Elena-Laura, Arrigo, Mattia, Ben Gal, Tuvia, Celutkiene, Jelena, Collins, Sean P., DeBacker, Daniel, Iliescu, Vlad A., Jankowska, Ewa, Jaarsma, Tiny, Keramida, Kalliopi, Lainscak, Mitja, Lund, Lars H, Lyon, Alexander R., Masip, Josep, Metra, Marco, Miro, Oscar, Mortara, Andrea, Mueller, Christian, Mullens, Wilfried, Nikolaou, Maria, Piepoli, Massimo, Price, Susana, Rosano, Giuseppe, Vieillard-Baron, Antoine, Weinstein, Jean M., Anker, Stefan D., Filippatos, Gerasimos, Ruschitzka, Frank, Coats, Andrew J.S., Seferovic, Petar·2020·European Journal of Heart Failure

Abstract

Cardiogenic shock (CS) is a complex multifactorial clinical syndrome with extremely high mortality, developing as a continuum, and progressing from the initial insult (underlying cause) to the subsequent occurrence of organ failure and death. There is a large spectrum of CS presentations resulting from the interaction between an acute cardiac insult and a patient’s underlying cardiac and overall medical condition. Phenotyping patients with CS may have clinical impact on management because classification would support initiation of appropriate therapies. CS management should consider appropriate organization of the health care services, and therapies must be given to the appropriately selected patients, in a timely manner, whilst avoiding iatrogenic harm. Although several consensus-driven algorithms have been proposed, CS management remains challenging and substantial investments in research and development have not yielded proof of efficacy and safety for most of the therapies tested, and outcome in this condition remains poor. Future studies should consider the identification of the new pathophysiological targets, and high-quality translational research should facilitate incorporation of more targeted interventions in clinical research protocols, aimed to improve individual patient outcomes. Designing outcome clinical trials in CS remains particularly challenging in this critical and very costly scenario in cardiology, but information from these trials is imperiously needed to better inform the guidelines and clinical practice. The goal of this review is to summarize the current knowledge concerning the definition, epidemiology, underlying causes, pathophysiology and management of CS based on important lessons from clinical trials and registries, with a focus on improving in-hospital management.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ejhf.1922

Cites

187 of 187 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 187 references

Cited by

See all 493

Metadata

Authors
Chioncel, O., Parissis, J., Mebazaa, A., Thiele, H., Desch, S., Bauersachs, J., Harjola, V.-P., Antohi, E.-L., Arrigo, M., Ben Gal, T., Celutkiene, J., Collins, S. P., DeBacker, D., Iliescu, V. A., Jankowska, E., Jaarsma, T., Keramida, K., Lainscak, M., Lund, L. H., Lyon, A. R., Masip, J., Metra, M., Miro, O., Mortara, A., Mueller, C., Mullens, W., Nikolaou, M., Piepoli, M., Price, S., Rosano, G., Vieillard-Baron, A., Weinstein, J. M., Anker, S. D., Filippatos, G., Ruschitzka, F., Coats, A. J. S., & Seferovic, P.
Venue
European Journal of Heart Failure
Published
2020-07-16
Volume
22
Issue
8
Pages
1315-1341
ISSN
  • 1388-9842 (ISSN-L)
  • 1879-0844
OpenAlex
W3029617361
Cited by
493
References
187
FWCI
17.84
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Epidemiology, Pathophysiology and Contemporary Management of Cardiogenic Shock – A Position Statement from the Heart Failure Association of the European Society of Cardiology. https://app.cochat.ai/papers/10.1002/ejhf.1922
The paper
Chioncel, O., Parissis, J., Mebazaa, A., Thiele, H., Desch, S., Bauersachs, J., Harjola, V.-P., Antohi, E.-L., Arrigo, M., Ben Gal, T., Celutkiene, J., Collins, S. P., DeBacker, D., Iliescu, V. A., Jankowska, E., Jaarsma, T., Keramida, K., Lainscak, M., Lund, L. H., . . . Seferovic, P. (2020). Epidemiology, Pathophysiology and Contemporary Management of Cardiogenic Shock – A Position Statement from the Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure. https://doi.org/10.1002/ejhf.1922

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.